You are here

  • Home
  • Archive
  • Volume 92, Issue 1
  • Effects of an ophthalmic formulation of meloxicam on COX-2 expression, PGE2 release, and cytokine expression in a model of acute ocular inflammation

Article info

Article menu

Download PDFPDF

Original Article
Effects of an ophthalmic formulation of meloxicam on COX-2 expression, PGE2 release, and cytokine expression in a model of acute ocular inflammation

Authors

  1. L Vega, Sección Externa de Toxicología, CINVESTAV, Av. IPN 2508, San Pedro Zacatenco, Mexico DF, 07360, Mexico; lvega{at}cinvestav.mx
View Full Text

Citation

Cruz R, Quintana-Hau JD, González JR, et al
Effects of an ophthalmic formulation of meloxicam on COX-2 expression, PGE2 release, and cytokine expression in a model of acute ocular inflammation
British Journal of Ophthalmology 2008;92:120-125.

Publication history

  • Accepted June 29, 2007
  • First published October 25, 2007.
Online issue publication 
July 29, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2008 BMJ Publishing Group